Our Commitment to HIV

For years, Teva has supported patients living with HIV and we continue to do so by delivering quality, cost-effective treatment options to patients. Let’s look at some facts:

FACT: Teva manufactures nearly 50% of HIV-related treatment on the World Health Organization's (WHO) Essential Medicines List - medications considered to be critical to meet public health needs.

  • Ten of the 12 HIV-related medicines Teva makes are featured on the WHO’s Essential medicine’s list.

FACT: In 2000, just 685,000 people living with HIV had access to antiretroviral therapy. By June 2019, approximately 4.5 million people had access to these important medicines. However, only 62% of all people living with HIV accessing treatment.

  • Teva is committed to making treatments accessible to more people. Over the past ten years, we’ve donated more than $50 million worth of HIV-related medicines to those in need.

  • Teva is the largest manufacturer of generic drugs in the U.S. and the world. We understand the importance of making quality medications accessible and affordable.

While we’ve made strides in preventing the spread of this potentially fatal virus, we also recognize the need to continue supporting communities and patients in addition to increasing access to treatment – especially during the COVID-19 pandemic, when access to treatment for immunocompromised patients is more important than ever. Consider these facts:

FACT: With increasing access to treatment and care, HIV has become a more manageable chronic condition.

Prevention is the first step for reducing HIV risk. Condom use is the most effective method for preventing STDs and HIV in any sexual encounter. A routine blood test can help monitor HIV status. There are also preventive medications that can be taken daily or after potential exposure.

FACT: Over the past few decades, the 38 millions people living with HIV/Aids have seen new treatment options.

  • In 2017, we launched five HIV medicines around the world and we continue to provide new treatment options to the HIV community.

Treating HIV is part of our broader mission to nurture healthy communities around the world, through our portfolio and beyond.

 

Footnotes

  1. Back to contents.

    IQVIA MIDAS MAT (Q3 2018, Q4 2018, Q1 2019, Q2 2019). Global analysis of 32 countries.

  2. Back to contents.

    World Health Organization. Essential Medicines List 21st Edition. 2019. Available: https://www.who.int/medicines/publications/essentialmedicines/UNEDITED_TRS_2019_EC22_Sept.pdf?ua=1

  3. Back to contents.

    UNAIDS announces nearly 21 million people living with HIV now on treatment. 2017. Available: https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2017/november/20171121_righttohealth_report

  4. Back to contents.

    World Health Organization. HIV/AIDS Key Facts. 2019.Available: https://www.who.int/news-room/fact-sheets/detail/hiv-aids

  5. Back to contents.

    Global HIV & AIDS statistics – 2019 fact sheet. 2019. Available: https://www.unaids.org/en/resources/fact-sheet

Share this article: